Clinical Trials Browser

Phase 2 × trebananib × Gynecologic × Clear all

NCT00479817 2019-12-18

Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01210222 2018-02-23

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

35 enrolled 9 charts

GynecologicSarcoma

Sarcoma, Endometrial Stromal